Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Pediatric Oncology
•
Thrombosis
•
Hematology
•
Pediatric Hematology
•
Benign Hematology
•
Hemostasis/Thrombosis
Are there any circumstances where you would consider bridging for patients on DOACs?
What if the surgery is within 30 days of the blood clot?
Related Questions
For patients with incidental findings of venous thromboembolism during workup of a treatable malignancy, how do you approach discontinuation after the treatment is complete?
Are SCDs contraindicated in patients with acute DVTs?
For a patient with May-Thurner syndrome and DVT, would you recommend anticoagulation for 3-6 months or indefinitely?
In a young female with severe osteoporosis due to congenital estrogen deficiency, can estrogen be prescribed if genetic testing for congenital disorders reveals a heterozygous Factor V Leiden mutation?
What is the ideal period to wait until curative surgery for patients with acute pulmonary embolism and solid malignancy?
Does your evaluation of a young person with spontaneous upper extremity DVT vary as compared to lower extremity DVT?
Would you anticoagulate a patient with splenic infarctions in the setting of CMV viremia?
Is it true that a ferritin above 200 essentially rules out iron deficiency?
Can you use apixaban or rivaroxaban in case of dabigatran failure?
How do you manage me anticoagulation in a patient with May Thurner Syndrome, who does not have history of thrombosis, and becomes pregnant?